BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31400636)

  • 41. Characterization of BAFF and APRIL subfamily receptors in rainbow trout (Oncorhynchus mykiss). Potential role of the BAFF / APRIL axis in the pathogenesis of proliferative kidney disease.
    Granja AG; Holland JW; Pignatelli J; Secombes CJ; Tafalla C
    PLoS One; 2017; 12(3):e0174249. PubMed ID: 28323891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TACI deficiency leads to alternatively activated macrophage phenotype and susceptibility to Leishmania infection.
    Allman WR; Dey R; Liu L; Siddiqui S; Coleman AS; Bhattacharya P; Yano M; Uslu K; Takeda K; Nakhasi HL; Akkoyunlu M
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4094-103. PubMed ID: 26170307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. APRIL promotes proliferation, secretion and invasion of fibroblast-like synoviocyte from rats with adjuvant induced arthritis.
    Chang Y; Jia X; Sun X; Xu S; Wu Y; Zhang L; Wei W
    Mol Immunol; 2015 Mar; 64(1):90-8. PubMed ID: 25466610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
    Lee JJ; Ozcan E; Rauter I; Geha RS
    Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway.
    Kern C; Cornuel JF; Billard C; Tang R; Rouillard D; Stenou V; Defrance T; Ajchenbaum-Cymbalista F; Simonin PY; Feldblum S; Kolb JP
    Blood; 2004 Jan; 103(2):679-88. PubMed ID: 14504101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA.
    Lyu MA; Cheung LH; Hittelman WN; Marks JW; Aguiar RC; Rosenblum MG
    Mol Cancer Ther; 2007 Feb; 6(2):460-70. PubMed ID: 17267661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor.
    Jacob CO; Yu N; Guo S; Jacob N; Quinn WJ; Sindhava V; Cancro MP; Goilav B; Putterman C; Migone TS; Stohl W
    Arthritis Rheum; 2013 Apr; 65(4):1043-54. PubMed ID: 23334904
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymorphisms in genes of the BAFF/APRIL system may constitute risk factors of B-CLL--a preliminary study on a Polish population.
    Jasek M; Wagner M; Sobczynski M; Wolowiec D; Kuliczkowski K; Woszczyk D; Kielbinski M; Kusnierczyk P; Frydecka I; Karabon L
    Tissue Antigens; 2015 Oct; 86(4):279-84. PubMed ID: 26268376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased expression of TACI on NOD B cells results in germinal centre reaction anomalies, enhanced plasma cell differentiation and immunoglobulin production.
    Banday VS; Thyagarajan R; Sundström M; Lejon K
    Immunology; 2016 Nov; 149(3):297-305. PubMed ID: 27444337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment-Induced BAFF Expression and B Cell Biology in Multiple Sclerosis.
    Smets I; Prezzemolo T; Imbrechts M; Mallants K; Mitera T; Humblet-Baron S; Dubois B; Matthys P; Liston A; Goris A
    Front Immunol; 2021; 12():676619. PubMed ID: 34122439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TACI attenuates antibody production costimulated by BAFF-R and CD40.
    Sakurai D; Kanno Y; Hase H; Kojima H; Okumura K; Kobata T
    Eur J Immunol; 2007 Jan; 37(1):110-8. PubMed ID: 17154264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A significant decrease of BAFF, APRIL, and BAFF receptors following mesenchymal stem cell transplantation in patients with refractory rheumatoid arthritis.
    Gowhari Shabgah A; Shariati-Sarabi Z; Tavakkol-Afshari J; Ghasemi A; Ghoryani M; Mohammadi M
    Gene; 2020 Mar; 732():144336. PubMed ID: 31935514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BAFF, involved in B cell activation through the NF-κB pathway, is related to disease activity and bone destruction in rheumatoid arthritis.
    Zhang LL; Xiao H; Zhang F; Wu YJ; Shu JL; Li Y; Tai Y; Xu SQ; Xu JH; Wei W
    Acta Pharmacol Sin; 2021 Oct; 42(10):1665-1675. PubMed ID: 33483588
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers.
    Figgett WA; Deliyanti D; Fairfax KA; Quah PS; Wilkinson-Berka JL; Mackay F
    J Autoimmun; 2015 Jul; 61():9-16. PubMed ID: 26027434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression.
    Arkatkar T; Jacobs HM; Du SW; Li QZ; Hudkins KL; Alpers CE; Rawlings DJ; Jackson SW
    Kidney Int; 2018 Oct; 94(4):728-740. PubMed ID: 29907458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells.
    Haselmayer P; Vigolo M; Nys J; Schneider P; Hess H
    Eur J Immunol; 2017 Jun; 47(6):1075-1085. PubMed ID: 28383107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BAFF receptor and TACI in B-1b cell maintenance and antibacterial responses.
    Dickinson GS; Akkoyunlu M; Bram RJ; Alugupalli KR
    Ann N Y Acad Sci; 2015 Dec; 1362():57-67. PubMed ID: 25962322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. APRIL and BAFF promote increased viability of replicating human B2 cells via mechanism involving cyclooxygenase 2.
    Mongini PK; Inman JK; Han H; Fattah RJ; Abramson SB; Attur M
    J Immunol; 2006 Jun; 176(11):6736-51. PubMed ID: 16709833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Garcinol, an acetyltransferase inhibitor, suppresses proliferation of breast cancer cell line MCF-7 promoted by 17β-estradiol.
    Ye X; Yuan L; Zhang L; Zhao J; Zhang CM; Deng HY
    Asian Pac J Cancer Prev; 2014; 15(12):5001-7. PubMed ID: 24998578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.